Office of Clinical Trials Management

The mission of the Office of Clinical Trials Management is to further the excellence, scope and efficiency of clinical research activities at the Rowan University-School of Osteopathic Medicine.

What is a Clinical Trial?

In a clinical trial (also called an interventional study), participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or changes to participants' behavior, for example, diet. Clinical trials may compare a new medical approach to a standard one that is already available or to a placebo that contains no active ingredients or to no intervention. Some clinical trials compare interventions that are already available to each other. When a new product or approach is being studied, it is not usually known whether it will be helpful, harmful, or no different than available alternatives (including no intervention). The investigators try to determine the safety and efficacy of the intervention by measuring certain outcomes in the participants. For example, investigators may give a drug or treatment to participants who have high blood pressure to see whether their blood pressure decreases.  (Source:   

Currently Enrolling Trials:

If you are interested in the listed studies below and/or would like to obtain more information, please contact the Office of Clinical Trials Management (contact information on the right hand side).

New Jersey Institute for Successful Aging
ELND005-AG201 (Harmony AD):   This study is being conducted to determine if an investigational drug given as a pill can safely reduce the symptoms of aggression and agitation in people with Alzheimer’s disease.

EMR 700568-012 (Premiere):   The purpose of this observational registry is to collect information about subjects who have participated in a clinical study involving the investigational drug known as cladribine for multiple sclerosis.  It is hoped that this information will help doctors gain a better understanding of the long-term health effects of receiving cladribine. 

NeuroMusculoskeletal Institute
MRZ SP 3002:   This study involves an investigational study medication for the treatment of spasticity symptoms after stroke in the lower limb.

A-tl-52120-169 and A-tl-52120-170:  The purpose of this research study is to evaluate Dysport® risks / side effects and for treating cervical dystonia. In this study, Dysport® will be compared with placebo treatment (i.e.dummy treatment that looks like the real treatment but contains no active ingredient). Dysport® is a neurotoxin which comes from the bacteria Clostridium Botulinum.  It is a natural toxin that works on the nerves and causes the muscles to relax.

Obstetrics & Gynecology
M12-671:   The purpose of this study is to evaluate an investigational drug called elagolix in subjects with moderate to severe pain associated with endometriosis (for example, painful menstruation, non-menstrual pelvic pain, and painful sexual intercourse). Subjects must be pre-menopausal and between the ages of 18-49, inclusive.

HC11515: The purpose of this study is to evaluate the efficacy of Transcranial Direct Current Stimulation (tDCS) in the treatment of major depression and bipolar depression. tDCS is noninvasive and has shown promising efficacy in recent studies. In this study, active tDCS will be compared with placebo treatment, but everyone will eventually have the opportunity to receive active treatment after the initial study period has ended. Participants will have their mood and cognition monitored regularly during the trial.

Contact Information

If you would like to learn more about the Office of Clinical Trials Management, you may contact:

Christine Beswick, BA, CCRP
Program Manager

Phone: (856) 566-6003
Fax: (856) 566-2773

One Medical Center Drive
Stratford, New Jersey 08084-1501
Technical contact for the web site
Privacy Statement